Paracetamol – Mechanism of Action

Introduction

Paracetamol (also known as Acetaminophen) is one of the most commonly used drugs for fever and mild-to-moderate pain. Unlike NSAIDs, it has minimal anti-inflammatory action and does not cause gastric irritation.

It is classified as:

  • An analgesic and antipyretic
  • Belonging to the para-aminophenol derivative class

Despite its widespread use, its exact mechanism of action has long been debated and is often misunderstood—making it a favorite question in exams like GPAT, NEET-PG, NIPER, MBBS, and NCLEX.

Stepwise Mechanism of Action of Paracetamol

  1. Central COX Inhibition (COX-3 Hypothesis):
    Paracetamol acts predominantly in the central nervous system (CNS). It inhibits cyclooxygenase (COX) enzymes, especially a brain-specific COX variant (possibly COX-3), leading to reduced synthesis of prostaglandins in the hypothalamus.
  2. Antipyretic Effect via Hypothalamus:
    By inhibiting prostaglandin E₂ (PGE₂) in the preoptic area of the hypothalamus, it lowers the set-point for body temperature → antipyretic effect.
  3. Analgesic Action (Spinal and Supraspinal Sites):
    Decreased central prostaglandin levels also reduce the activation of pain receptors → analgesic effect.
  4. No Peripheral Anti-inflammatory Effect:
    In peripheral tissues, high levels of peroxides in inflamed areas limit paracetamol’s COX inhibition, explaining its poor anti-inflammatory action.
  5. TRPV1 & Serotonin Modulation (Additional):
    Emerging evidence suggests that paracetamol’s metabolites (like AM404) may also activate TRPV1 receptors and enhance serotoninergic descending pain pathways—contributing to analgesia.

Pharmacokinetic Parameters of Paracetamol

ParameterValue
Bioavailability60–90% (oral)
Onset of Action30–60 minutes
Half-life2–3 hours
Protein Binding20–25%
MetabolismLiver (Phase I & II – glucuronidation, sulfation)
ExcretionRenal (as conjugates)

At high doses, metabolism shifts to CYP2E1 pathway, producing the toxic metabolite NAPQI → hepatotoxicity risk.

Clinical Uses of Paracetamol

  • Fever (any age group, preferred antipyretic in children)
  • Mild to moderate pain: headache, muscle pain, dental pain
  • Osteoarthritis (preferred in patients with GI risk)
  • Safe option in gastritis or peptic ulcer disease
  • Can be used in pregnancy

Adverse Effects of Paracetamol

  • Hepatotoxicity in overdose due to NAPQI accumulation
  • Rare: skin reactions (Stevens-Johnson syndrome), anemia
  • Usually safe at therapeutic doses

🛡️ Antidote: N-acetylcysteine (NAC) – restores hepatic glutathione and detoxifies NAPQI.

Comparative Analysis: Paracetamol vs Ibuprofen

FeatureParacetamolIbuprofen
Anti-inflammatoryMinimalStrong
AntipyreticYesYes
Gastric irritationRareCommon (COX-1 inhibition)
Platelet effectNoneMild, reversible inhibition
Preferred in childrenYesYes (but avoid long-term use)
Liver toxicity riskYes (overdose)Minimal
Kidney safetySafer (unless prolonged/high dose)Nephrotoxic risk in dehydration

Practice MCQs

Q1. The primary mechanism of paracetamol’s antipyretic effect is:
A. COX-1 inhibition in peripheral tissues
B. Inhibition of PGE₂ synthesis in hypothalamus ✅
C. Activation of opioid receptors
D. Suppression of histamine release


Q2. Which organ is primarily affected in paracetamol toxicity?
A. Kidney
B. Liver ✅
C. Brain
D. Heart


Q3. The antidote for acute paracetamol poisoning is:
A. Atropine
B. Naloxone
C. N-acetylcysteine ✅
D. Activated charcoal


Q4. Why does paracetamol lack anti-inflammatory action?
A. It inhibits prostacyclin only
B. It acts only on peripheral COX
C. It’s a weak inhibitor of COX-2
D. Peroxide-rich environments reduce its efficacy ✅


Q5. Paracetamol is safe in which of the following conditions?
A. Severe liver disease
B. Peptic ulcer disease ✅
C. Chronic alcoholism
D. Uncontrolled diabetes


Q6. The toxic metabolite responsible for liver injury in overdose is:
A. Acetylsalicylate
B. AM404
C. NAPQI ✅
D. Serotonin


Q7. Which phase of metabolism converts paracetamol to safe conjugates?
A. Phase 0
B. Phase I oxidation
C. Phase II glucuronidation & sulfation ✅
D. CYP3A4 hydroxylation


Q8. The TRPV1 receptor involvement in paracetamol MOA is linked to:
A. Fever reduction
B. Analgesic effect ✅
C. Vasodilation
D. Platelet inhibition


Q9. Which statement is FALSE about paracetamol?
A. It can be given to infants
B. It is a good anti-inflammatory agent ✅
C. It acts centrally
D. It is safer for gastric patients


Q10. Which statement is TRUE?
A. Paracetamol causes GI bleeding like aspirin
B. It irreversibly inhibits COX-2
C. It works via prostaglandin suppression in CNS ✅
D. It enhances serotonin breakdown


FAQs

Q1: Can paracetamol be used in pregnancy?
Yes, it is considered safe when used in recommended doses.

Q2: Is paracetamol an NSAID?
No, it lacks significant anti-inflammatory properties and does not affect platelets or gastric mucosa like traditional NSAIDs.

Q3: What happens in paracetamol overdose?
It leads to the accumulation of NAPQI, a hepatotoxic metabolite, causing potential liver failure.

Q4: How soon should N-acetylcysteine be given after overdose?
Best within 8 hours of ingestion for maximum effectiveness.

References

Authors

  • Pharmacy Freak Editorial Team is the official editorial voice of PharmacyFreak.com, dedicated to creating high-quality educational resources for healthcare learners. Our team publishes and reviews exam preparation content across pharmacy, nursing, coding, social work, and allied health topics, with a focus on practice questions, study guides, concept-based learning, and practical academic support. We combine subject research, structured editorial review, and clear presentation to make difficult topics more accessible, accurate, and useful for learners preparing for exams and professional growth.

  • Harsh Singh Author Pharmacy Freak

    Harsh Singh Rajput is a pharmacist currently working at ESIC and holds an MBA in Pharmaceutical Management from NIPER Hyderabad. He has a strong academic record with top ranks in national-level pharmacy exams, including AIR 61 in NIPER 2024 (MS/M.Pharm), AIR 27 in NIPER MBA, AIR 147 in GPAT 2024, AIR 907 in GPAT 2023, and AIR 6 in AIIMS CRE-2025 for Drug Store Keeper. At PharmacyFreak.com, he contributes expert content, exam strategies, and practical guidance for future pharmacists.
    Mail- harsh@pharmacyfreak.com

2 thoughts on “Paracetamol – Mechanism of Action”

  1. I FREAKING LOOOVEEEEEE UUUU @PHARMACYFREAK 🩷🩷🩷🥹website fr fr…. idk why I didn’t discovered this website sooner 😭😭 Anyways, after discovering it 1 day before exam, I am still thankful 🫶🏻🫶🏻🫶🏻

    Reply

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators